Fibrogen Cash Flow - Annual (NASDAQ:FGEN)

Add to My Stocks
$57.35 $0.55 (0.97%) FGEN stock closing price Sep 18, 2018 (Closing)

For analyzing any company like Fibrogen from an investment perspective, its important to check the cash flow statement. While its important to look at the Fibrogen debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Fibrogen revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Fibrogen had cash and cash equivalents of $173.78M at beginning of the year and $673.65M at year end for 2017. Fibrogen cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. FGEN increase in investments stood at a value of $69.86M for the latest year 2017.

View details of Fibrogen cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow7.94M8.76M8.67M5.12M5.92M6.5M
Net Increase (Decrease) in Assets Liabilities14.34M28.13M30.95M58.1M31.79M16.26M
Cash From (used in) Discontinued Operations------
Other Adjustments Net37.4M31.88M27.57M18.68M3.14M4.19M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-8.49M-1.25M-1.97M-8.1M-6.8M-0.74M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments78.36M7.87M-3.89M-99.18M17.58M19.89M
Other Cash Inflow (Outflow) from Investment Activities------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares506.11M9.88M12.74M177.63M--
Issuance (Repayment) of Debt Securities-0.4M-0.4M-0.4M-0.4M--0.71M
Increase (Decrease) in Bank & Other Borrowings------
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities-9.24M-2.74M--3.13M-7.37M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--0.01M-0.03M-0.09M--0.06M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year173.78M153.32M165.45M76.33M38.87M18.58M
Cash & Equivalents at Year End673.65M173.78M153.32M165.45M76.33M38.87M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Fibrogen stock comparison chart provides an easy way to compare the stock price with peers along with details of Fibrogen stock price history.
The statement of cash flows can be categorized into three main sections:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Fibrogen is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Fibrogen stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Fibrogen lost $-66.51M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a positive value of $69.86M for FGEN stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash flow from financing activities shows the flow of cash between Fibrogen and its owners and creditors and was $496.47M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Fibrogen Cash Flow